Warner Law Offices has recently become aware that the Type 2 diabetes drug, Invokana, puts users at an increased risk for leg, foot and toe amputations. The FDA issued the first safety warning regarding Invokana and amputation based on interim analysis of two clinical trials. Both studies have now been concluded and final results confirm that Invokana may double the amputation risk. Based on these final results, the FDA has issued a more severe, "black box warning" for Invokana.
According to an observational study published in JAMA Internal Medicine, people taking Xarelto (rivaroxaban) may be more likely to have a serious bleeding event than those taking Pradaxa (dabigatran). Johnson and Johnson (J&J) is facing more the 15,000 Xarelto lawsuits.
By: Attorney Bobby Warner
A study recently published by JAMA Pediatrics has provided evidence that acetaminophen, the active ingredient in Tylenol and other over the counter medications, could cause a pregnant mother's offspring to have a hyperactivity disorder.
Invokana and Invokamet (canagliflozin), Farxiga, and Xigduo XR (dapagliflozin) are drugs used to lower blood sugar in Type 2 diabetes. They are very popular drug, but unfortunately they have been associated with acute kidney damage. There was already a warning about this risk, and on June 14, 2016, The U.S. Food and Drug Administration (FDA) announced that it was strengthening its existing warning. If you have been harmed by Invokana, Farxiga, or another diabetes medication, you may be entitled to substantial compensation.
Some popular drugs used to treat Type 2 diabetes have come under scrutiny after a new research indicates that some diabetes drugs may cause pancreatic changes that can lead to pancreatic cancer. The drugs studied were Januvia, Byetta and some other diabetes drugs often prescribed to patients in the U.S.